Correlation Between CureVac NV and Karuna Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CureVac NV and Karuna Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CureVac NV and Karuna Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CureVac NV and Karuna Therapeutics, you can compare the effects of market volatilities on CureVac NV and Karuna Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CureVac NV with a short position of Karuna Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of CureVac NV and Karuna Therapeutics.

Diversification Opportunities for CureVac NV and Karuna Therapeutics

-0.08
  Correlation Coefficient

Good diversification

The 3 months correlation between CureVac and Karuna is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding CureVac NV and Karuna Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Karuna Therapeutics and CureVac NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CureVac NV are associated (or correlated) with Karuna Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Karuna Therapeutics has no effect on the direction of CureVac NV i.e., CureVac NV and Karuna Therapeutics go up and down completely randomly.

Pair Corralation between CureVac NV and Karuna Therapeutics

Given the investment horizon of 90 days CureVac NV is expected to under-perform the Karuna Therapeutics. In addition to that, CureVac NV is 2.64 times more volatile than Karuna Therapeutics. It trades about -0.05 of its total potential returns per unit of risk. Karuna Therapeutics is currently generating about -0.09 per unit of volatility. If you would invest  22,016  in Karuna Therapeutics on August 27, 2024 and sell it today you would lose (1,705) from holding Karuna Therapeutics or give up 7.74% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy13.99%
ValuesDaily Returns

CureVac NV  vs.  Karuna Therapeutics

 Performance 
       Timeline  
CureVac NV 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CureVac NV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Karuna Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Karuna Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Karuna Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

CureVac NV and Karuna Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CureVac NV and Karuna Therapeutics

The main advantage of trading using opposite CureVac NV and Karuna Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CureVac NV position performs unexpectedly, Karuna Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Karuna Therapeutics will offset losses from the drop in Karuna Therapeutics' long position.
The idea behind CureVac NV and Karuna Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios